NCT07871877: Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 60 planned
- Started
- 1 Jul 2027
- Primary completion
- 31 Jan 2029
- Arms
- Recent-Use Ibogaine With Placebo Injection and SENTINEL, Randomized Ibogaine With Placebo Injection and SENTINEL
- Results
- None posted
- 13 Oct 2026: Trial registered